Raleigh, NC, United States of America

Santoshkumar Khatwani


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Work of Santoshkumar Khatwani in Viral Capsid Research

Introduction

Santoshkumar Khatwani, based in Raleigh, NC, is an accomplished inventor recognized for his significant contributions to the field of viral research. With a patent to his name, Khatwani has demonstrated his expertise and commitment to advancing scientific knowledge in virology and pharmaceutical applications.

Latest Patents

Khatwani’s patent titled "Separation and Quantification of Empty and Full Viral Capsid Particles" introduces valuable methods for differentiating and measuring empty and full viral capsids, specifically adeno-associated virus (AAV) capsids. This innovative approach is critical for improving the efficacy of viral preparations used in pharmaceutical compositions and drug products.

Career Highlights

Currently employed at Sangamo Therapeutics, Inc., Khatwani plays an integral role in research and development, focusing on gene therapy and advanced treatment options. His work is pivotal in enhancing the methodologies used in viral therapeutics, contributing to the development of safer and more effective treatments.

Collaborations

Throughout his career, he has collaborated with notable professionals, including colleague Zhu Pirot, fostering a synergistic environment for innovation and research advancement. These partnerships are essential in tackling complex challenges within the field of virology and ensuring the success of their innovative solutions.

Conclusion

Santoshkumar Khatwani exemplifies the spirit of innovation in the scientific community. His patent on viral capsid quantification serves as a testament to his expertise and dedication to improving therapeutic approaches. As he continues his work at Sangamo Therapeutics, he remains a vital figure in the pursuit of groundbreaking advancements that could transform the treatment of viral-related diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…